Fertin, officially known as Fertin Pharma A/S, is a leading player in the chemicals nec industry, headquartered in Denmark (DK). Founded in 2006, the company has established itself as a pioneer in the development and manufacturing of innovative pharmaceutical and consumer health products, particularly in the realm of oral delivery systems.
With a strong operational presence across Europe and North America, Fertin is renowned for its unique expertise in gum-based delivery technologies, which enhance the efficacy of active ingredients. The company has achieved significant milestones, including partnerships with major global brands, solidifying its market position as a trusted provider of high-quality solutions. Fertin's commitment to research and development continues to drive its success, making it a notable name in the chemicals sector.
+28 vs industry average
Fertin’s score of 57 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Fertin?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Chemicals is among the most carbon-intensive industries
Industry performance
The Chemicals industry has reduced its overall emissions by 6% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Fertin's reported carbon emissions
Fertin, a Danish chemicals company, has reported its greenhouse gas emissions for recent years. In 2024, the company's total emissions were approximately 41.9 million kg CO2e. This figure comprises Scope 1 emissions of about 3.65 million kg CO2e, Scope 2 emissions (market-based) of approximately 1.54 million kg CO2e, and Scope 3 emissions totalling around 36.67 million kg CO2e.
For 2023, Fertin's total emissions stood at approximately 41.6 million kg CO2e. This breakdown includes Scope 1 emissions of about 4.74 million kg CO2e, Scope 2 (market-based) emissions of approximately 1.87 million kg CO2e, and Scope 3 emissions of around 34.26 million kg CO2e.
Prior to 2023, more detailed scope breakdowns are not available, with reported figures focusing on Scope 1 and 2 combined. In 2022, Fertin reported Scope 1 and 2 market-based emissions of about 3.68 million kg CO2e. The previous year, 2021, saw Scope 1 and 2 market-based emissions at approximately 3.59 million kg CO2e.
Fertin's climate commitments and reduction targets are cascaded from its parent organisation, Philip Morris International Inc. Fertin Pharma A/S is noted as the source for performance data at a 0 cascade level, while climate initiatives such as SBTi targets and RE100 are sourced from Philip Morris International Inc. at a level 2 cascade. Specific details on reduction targets or achievements for Fertin itself are not provided in the latest data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Fertin’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Fertin yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Fertin
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project